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http://dx.doi.org/10.1016/j.pedneo.2Background: The aim of this study was to determine the rate of health care-associated infec-
tion (HC-AI) and device-associated health care-associated infections (DA-HAIs), and distribu-
tion of causative microorganisms and etiologic factors responsible for these infections in a
neonatal intensive care unit (NICU) of a state hospital in southeastern Turkey.
Methods: A laboratory-based, active, prospective nosocomial infection surveillance study was
performed in NICUs from January 2008 to December 2011. The rates of HC-AIs were deter-
mined on a daily basis. The findings were evaluated by applying the definitions of the Centers
for Disease Control and Prevention National Healthcare Safety Network.
Results: In a 4-year period, 580 HC-AIs, 81 of which were DA-HAIs, were detected among 6932
patients. The rate of hospital acquired infection was 8.3% and 7.69/1000 patient days.
Ventilator-associated pneumonia (VAP) was the second most frequent (13.1%) HC-AI and the
most frequent was DA-HAI. The VAP rate was 6.4 per 1000 ventilator days. Mechanical ventila-
tion was the most frequently used invasive device. Median time to diagnosis of VAP was
32.11  29.3 days from the time of admission. Acinetobacter baumannii (48%) and Pseudo-
monas aeruginosa (32%) were the most frequent microorganisms. Colistin was the mostof Infectious Disease and Clinical Microbiology, Dicle University, School of Medicine, Yenis‚ehir 21280,
.com (R. Tekin).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
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304 R. Tekin et aleffective antibiotic by in vitro test. The antibiotic resistance ratios of A. baumannii were 54%
for carbapenems, aminoglycosides, and cefoperazoneesulbactam; 88% for quinolones; and
92% for ceftazidime, ceftriaxone, and piperacillinetazobactam.
Conclusions: Device-associated nosocomial infections was a particularly important problem in
NICU. Close monitoring will decrease the rates of device-related nosocomial infections.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Health care-associated infections (HC-AIs) are a major
cause of morbidity and mortality in neonatal intensive care
units (NICUs) and lead to increases in hospital length of stay
and treatment cost. HC-AIs rates in the NICU vary between
1.8% and 74.3% in several reports, and this rate has
increased gradually.1e7 In Turkey, HC-AI rates in NICUs were
reported to range from 2% to 66%.2 Higher nosocomial
infection incidence in NICUs was related to longer duration
of hospital stay, and invasive interventions and medical
treatments. HC-AIs, especially device-associated health
care-associated infections (DA-HAIs), were also common in
newborns because of their insufficient immune system and
mechanical barriers, as well as lack of protective flora.8
Surveillance of DA-HAI plays a substantial role in infec-
tion control in the intensive care unit. Surveillance was
reported to be an efficacious tool to reduce DA-HAIs by the
Centers for Disease Control and Prevention’s (CDC) Study of
the Efficacy of Nosocomial Infection Control Project.9,10
The CDC’s National Nosocomial Infections Surveillance
System (NNIS) and National Healthcare Safety Network re-
ported standardized criteria and methods for DA-HAI sur-
veillance.11 According to the CDC, use of DA-HAI rates was a
valuable method. Some studies on rates of DA-HAI in NICUs
used the standardized definitions. However, in the litera-
ture no detailed study was performed within extended
periods and evaluating hospital stays and mortality rates
according to birth weight in newborns.12
In the present study, our aim was to detect the rates of
HC-AIs and DA-HAIs, and evaluate hospital stays and mor-
tality rates according to birth weights of newborns in NICUs.
In addition, we intended to detect the distribution and
antibiotic susceptibility of frequent causative microorgan-
isms that were isolated from DA-HAIs in NICU.2. Materials and Methods
In this study, the data of the patients who were hospitalized
because of infectious and noninfectious causes in Diyarbakır
Children’s Hospital Neonatal Intensive Care Unit, between
January 1, 2008 and December 31, 2011, were prospectively
collected. The data of patients who were diagnosed with
HC-AI were subsequently evaluated. Diyarbakir Children’s
Hospital,which is located in southeast Turkey, is a second-line
ministry of health hospital with a 567-bed capacity and pro-
vides both outpatient and inpatient services. The neonatal
unit of this hospital has a total of 49 incubators, 17mechanical
ventilators, and four open intensive care beds. Patients werefollowed up by the neonatal specialist in this hospital. A total
of 6932 patients who were admitted to the NICU were fol-
lowed between 2008 and 2011. We performed a patient and
laboratory-based, active, and prospective nosocomial infec-
tion surveillance study. The ratios of health care-associated
hospitalized infection and invasive device utilization, and the
rates of invasive device associated infectionwere determined
by an infectious disease specialist and two infection control
nurses on a daily basis. Data on blood, urine, sputum, cere-
brospinal fluid, wound, catheter cultures, and endotracheal
aspirate cultures were obtained from inpatients under suspi-
cion of HC-AI. The BACTEC peds plus/F [Becton, Dickinson,
and Company(BD), Sparks, MD, USA] culture vials were used
for blood samples. Identification and antibiotic susceptibility
of microorganisms were performed using the Phoenix (BD)
automated identification system, and the results were eval-
uated in accordancewith the recommendations of theClinical
and Laboratory Standards Institute.13 In addition to the
culture results, laboratory findings such as peripheral blood
leukocyte count, platelet count, and C-reactive protein
value, and the existence of a new radiographic infiltratewere
recorded. Clinical signs such as fever, lung signs, and hypo-
tension were also recorded. The clinical findings, culture re-
sults, and radiographic and laboratory data were recorded in
the standard form prepared by the NNIS System on a daily
basis.14 However, these laboratory and radiographic findings
were not evaluated.
The overall infection rates were calculated by dividing
infection episodes by total patient days, multiplied by
1000. Device-associated infection rates were calculated by
dividing the number of episodes by total device days,
multiplied by 1000. Device utilization rates were also
calculated, dividing device days by total patient days. The
diagnosis of hospital-acquired infection was performed on
the basis of the criteria defined by the CDC. According to
these criteria, hospital-acquired infection was defined as
one that was neither present nor incubating at the time of
the patient’s admission but had its onset during hospitali-
zation.15 Ventilator-associated pneumonia (VAP) was
defined as nosocomial pneumonia in a patient on mechan-
ical ventilatory support (by endotracheal tube or trache-
ostomy) for >48 hours.11 Umbilical catheter-associated
bloodstream infection (UC-BSI) was defined as an infec-
tion where an umbilical catheter was in place at the time of
or 48 hours prior to onset of the event.16
3. Results
In the 4-year period of the study, 580 HC-AIs were detected
from 6932 patients, 81 of which were DA-HAIs. Rates of
Device-associated Nosocomial Infections 305hospital acquired infection were found to be 8.3% and 7.69/
1000 patient days in the NICU. Bloodstream infections (BSIs;
76%) were the most frequent HC-AIs, with a rate of 6.4/1000
patient days. VAP was the second most frequent HC-AI
(13.1%) with a rate of 1.1/1000 patient days. Distribution
of numbers, percentages, and incidence rates of HC-AIs
according to infection site are presented in Table 1. In this
study, 76 DA-HAIs were VAPs and five DA-HAIs were umbilical
catheter-related infections. The VAP rate was 6.4 per 1000
ventilator days, and the umbilical catheter-related infection
rate was 2.6 per 1000 catheter days. Mechanical ventilation
was the most frequently used invasive device with ventila-
tion days of 11,939. Rates of DA-HAI per 1000 device-days and
device utilization ratios for 4 years are presented in Table 2.
Median time to diagnosis of VAP was 32.11  29.3 days from
the time of admission. Demographic characteristics of pa-
tients diagnosed with VAP in NICU are presented in Table 3.
Acinetobacter baumannii (48%) and Pseudomonas aerugi-
nosa (32%) were the most frequent microorganisms isolated
from DA-HAI infections. Colistin was found to be the most
effective antimicrobial against both A. baumannii and
P. aeruginosa by in vitro susceptibility tests. Distribution of
isolatedmicroorganisms from DA-HAIs according to the years
and their antibiotic susceptibility ratios are presented in
Tables 4 and 5, respectively.
4. Discussion
Development of new treatment options and life support
techniques in neonatology has increased the survival rates
of newborns. However, nosocomial infections have become
a major problem in the NICU because of prolonged dura-
tions of hospital stay.
In several reports, the rates of HC-AIs in NICU have been
reported to vary between 1.8% and 74.3% and between 4.8
and 22 per 1000 patient days.1e7,17e21 In Turkey, the rate of
HC-AI were found to be 11.3%, 16.1/1000 patient days in
Marmara University Hospital patient days in Marmara
University Hospital.22 In the present study, the rate of HC-AI
was in the range of values specified in other studies.Table 1 Distribution of health care-associated infections
(HC-AI) according to the infection sites in a neonatal
intensive care unit, 2008e2011 and the units of the inci-
dence rates (per 1000 patient days).











Conjunctivitis 25 4.3 0.4
Pneumonia 22 3.8 0.3
Catheter infection 5 0.9 0.07
Skin and soft tissue
infection
5 0.9 0.07
Surgery site infection 3 0.5 0.04
Meningitis 1 0.1 0.01
Total 580 100.0 8.3BSIs are the most frequent HC-AIs in NICUs worldwide. In
a study from Colombia, the most frequent HC-AIs were BSIs
(72.7%), followed by pneumonia (18.2%), in NICUs.20,23 In
the current study, BSIs were the most frequently encoun-
tered health care infections with a rate of 76.4%, and VAPs
were the second most frequently encountered infections
with a rate of 13.1% in NICUs, which is consistent with the
data reported in the literature. The frequency of the BSIs
and VAPs may be due to the common usage of invasive
catheters and ventilators in NICUs.
Many studies have shown that rates of DA-HAIs vary ac-
cording to the site of infection. In a study conducted in El
Salvador, the rate of DA-HAI was found to be 9.8 per 1000
ICU days in NICUs and central catheter-associated blood-
stream infection (CVC-BSI) rate was found to be 9.9, and
the VAP rate was 16.1 per 1000 catheter days.12 In a Saudi
Arabian study, the incidence per 1000 device-days was re-
ported as 8.2 for CVC-BSI and 10.5 for UC-BSI in NICUs.24 In
a Turkish study, the VAP rate was 13.76/1000 ventilator
days with a ventilator utilization ratio of 0.29, and the CVC/
UC-BSI rate was 3.8/1000 catheter days with a catheter
utilization ratio of 0.24.25 In our study, the VAP rate was
found to be 6.4 per 1000 ventilator days, and UC-BSI was 2.6
per 1000 catheter days. These data showed that our rates
had lower limits than those given in other reports but in
substantial levels. Therefore, we thought that new mea-
sures related to ventilator and umbilical catheter utiliza-
tion were necessary at our hospital.
The factors related to VAP include premature birth, a
weak immune system, increased permeability of the mu-
cous membranes, prolonged intubation, prolonged me-
chanical ventilation, empirical antibiotic usage, use of H2
blockers and antacids, prior BSI, low birth weight, opiate
treatment, and reintubation.25 In a Canadian study, the
incidence of nosocomial infection was reported to be
6.7e74.5% in infants with low birth weight and 0.1e17% in
infants with higher birth weight.3 In a Turkish study,
ventilator utilization ratio was highest for patients with
birth weight 1000 g.25 In our study, VAP rate in infants
with birth weight <1000 g was higher than that in infants
with birth weight >2500 g. We considered that the in-
crease in birth weight and gestational age resulted in
completion of the respiratory system and led to decrease
of VAP rates in infants. In addition, we observed that VAP
frequency was closely related to prolonged ventilation in
our hospital in accordance with the literature.25 Some
authors suggested that noninvasive ventilation, such as
nasal continuous positive pressure ventilation or nasal
synchronized intermittent mandatory ventilation, signifi-
cantly decreased the frequency of VAP when compared to
invasive methods.25
In the present study, the UC-BSI rate was higher in in-
fants with birth weight >2500 g. This may be related with
lower umbilical catheter days in these patients.
According to the literature and in agreement with our
study, longer duration of hospitalization was related to an
increase of hospital-acquired infection.2,5,26,27 In many
studies, it was reported that patients with hospital-
acquired infection were usually diagnosed after the 2nd
week of hospital admission. In Canada, median time to
diagnosis of HC-AI was found to be 15e19 days, in South
Korea 15e18 days, and in South America 17  14 days from
Table 2 Rates of device-associated infections (DA-HAI) per 1000 device-days and device utilization ratios in a neonatal
intensive care unit, 2008e2011.
<1000 1001e1500 1501e2500 >2500 Total
Number of patients 334 882 2175 3541 6932
Patient days 5440 18,809 25,867 25,291 75,407
Ventilation days 1992 2518 3190 4239 11,939
Number of VAP 17 21 19 19 76
Ventilatory utilization ratio 0.36 0.13 0.12 0.16 0.15
Rate of VAP 8.5 8.3 5.9 4.4 6.4
Umbilical catheter days 691 502 454 261 1908
Number of umbilical catheters d 1 1 3 5
Umbilical catheter utilization ratio 0.12 0.02 0.01 0.01 0.02
Rate of UC-BSI d 2 2.2 11.4 2.6
UC-BSI Z umbilical catheter-associated bloodstream infection; VAP Z ventilator-associated pneumonia.
306 R. Tekin et althe time of admission.3,28,29 In the present study, median
time to diagnosis of VAP was 32.11  29.3 days from the
time of admission. These results show that we need a closer
follow-up of our NICU patients.
In our study, A. baumannii and P. aeruginosa were the
most frequently isolated microorganisms from VAP. Both
the NNIS in the United States and the European MulticenterTable 3 Demographic characteristics of patients diag-
nosed with ventilator-associated pneumonia (VAP) in a
neonatal intensive care unit, 2008e2011.
n Z 69 (%) or Average 














Length of hospital stay (d) 73.7  50.9 (13e237)
1000 116.6  58.6 (47e237)
1001e1500 84.3  50.8 (27e213)
1501e2500 53  25.3 (22e110)
2501 46.3  35.2 (13e147)
Hospital day on the onset of VAP 28.7  26.3 (4e132)
Hospital day of the
detection of VAP
32.11  29.3 (4e150)
Hospital stay after the
onset of VAP
46.1  40.7 (1e197)
Day of death (based on
admissions)
70.3  51.4 (13e233)
Hospital mortality 9 (13)Study Group found that pneumonia was most often associ-
ated with P. aeruginosa and Staphylococcus aureus in their
pediatric populations.30 In a prospective cohort study of
VAP, the organisms most commonly isolated from tracheal
cultures included S. aureus (23%), P. aeruginosa (38.4%),
Enterobacter spp. (38.4%), and Klebsiella spp. (23%).31 The
dominance of Gram-negative microorganisms may be
caused by frequency implementation of ventilator, aspira-
tion of colonizing microorganisms, and biofilm formation.
Our study also demonstrated that incidence of A. bau-
mannii increased in hospital settings, and colistin was the
most effective antibiotic against A. baumannii by in vitro
susceptibility tests. By contrast, the antibiotics resistance
ratios of our isolates were in significant levels. We sug-
gested that antibiotic usage policies be reviewed in our
hospital, that distinction of infection or colonization be
made in our patients, and that unnecessary use of antibi-
otics be avoided.
In conclusion, our study revealed that the infection
control was a significant problem in NICUs. We suggest that
the infection control measures such as ensuring of hand
hygiene compliance, prevention of frequent use ofTable 4 Microorganisms isolated from patients with pos-
itive endotracheal aspirate cultures and umbilical catheter
cultures in a neonatal intensive care unit, 2008e2011.
Microorganism types VAP UC-BSI Total, n (%)
Acinetobacter baumannii 22 2 24 (48)
Pseudomonas aeruginosa 15 1 16 (32)
Klebsiella spp. 3 d 3 (6)
Staphylococcus aureus 1 d 1 (2)
Escherichia coli 1 d 1 (2)
Enterobacter spp. 1 d 1 (2)
Serratia marcensces 1 d 1 (2)
Enterococcus faecium d 1 1 (2)
Burkholderia cepacia 1 d 1 (2)
Candida spp. 1 d 1 (2)
Total 46 4 50 (100)
UC-BSI Z umbilical catheter-associated bloodstream infection;
VAP Z ventilator-associated pneumonia.
Table 5 Antibiotic susceptibility of Acinetobacter baumannii and Pseudomonas aeruginosa strains isolated from positive
endotracheal cultures and catheter cultures in a neonatal intensive care unit, 2008e2011.






Amikacin 2 (8) 7 (29) 15 (63) 0 (0) 14 (93) 1 (7)
Gentamicin 2 (8) 10 (42) 12 (50) 1 (7) 13 (86) 1 (7)
Levofloxacin 12 (50) 3 (12) 9 (38) 0 (0) 11 (72) 4 (28)
Imipenem 3 (12) 10 (42) 11 (46) 2 (12) 10 (63) 4 (25)
Meropenem 2 (8) 11 (46) 11 (46) 1 (6) 11 (69) 4 (25)
Colistin 0 (0) 16 (100) 0 (0) 0 (0) 11 (100) 0 (0)
Piperacillinetazobactam 2 (8) 1 (4) 21 (88) 2 (14) 11 (72) 2 (14)
Cefepime d d d 1 (7) 12 (75) 2 (25)
Cefoperazoneesulbactam 2 (8) 10 (42) 12 (50) d d d
Ceftazidime 2 (8) 2 (8) 20 (84) 0 (0) 12 (79) 4 (21)
Ceftriaxone 0 (0) 1 (4) 23 (96) 1 (7) 1 (7) 13 (86)
Ciprofloxacin 0 (0) 3 (12) 21 (88) 2 (14) 11 (72) 2 (14)
Trimethoprimesulfamethoxazole 0 (0) 11 (46) 13 (54) 0 (0) 1 (12) 7 (88)
Device-associated Nosocomial Infections 307mechanical ventilation, umbilical catheter, central venous
catheter, reduction of the duration of hospital stay of pa-
tients, and prevention of improper use of antibiotics will
contribute to reducing the incidence of HC-AI and device-
associated infections.
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